What's in the 2026 Australian Flu Vaccine — and Who's Accountable for It
What your employees actually receive this season, delivered by AHPRA-registered nurse immunisers and reported to AIR — the clinical detail behind every Corporate Care dose.
Request a QuoteWhat’s actually in the dose your employees receive in 2026
The 2026 Australian flu vaccine is a trivalent inactivated influenza vaccine (TIV) covering the three strains the Australian Influenza Vaccine Committee recommended for the Australian season: two influenza A subtypes (H1N1 and H3N2) and one influenza B lineage (Victoria).
The B/Yamagata lineage has not been detected in global circulation since 2020, which is why every flu vaccine on the Australian market in 2026 is trivalent. For the practical difference between the two types, see influenza A vs influenza B, explained.
Egg-based and cell-based options are both available on the Australian market; Corporate Care administers egg-based inactivated injectable TIV across all standard workplace clinics.
Corporate Care purchases the dose your employees receive through licensed Australian wholesale supply, holds it in a calibrated cold-chain kit between 2°C and 8°C from leaving the wholesaler to the moment it enters the syringe, and reports it to the Australian Immunisation Register the same day.
The vaccine itself is the easy part. The work is in the chain of custody between TGA batch release and the clinic-day chair, and in the chain of accountability that follows the dose after it’s administered.
That chain of custody and accountability runs through our workplace flu vaccination clinics.
Built and clinically led by nurses since 2010
Corporate Care was founded by Aitor Aspiazu, a Registered Nurse, in 2010. The clinical side of the business has been led by nurses ever since. Not procured from a third-party agency, not subcontracted to a clinic chain, not bolted onto a logistics company. The Registered Nurses who deliver your clinic are Corporate Care’s own people, with current AHPRA registration and HESA-accredited workplace immunisation training.
One organisation, one clinical lead, one way of working in every state. The team that plans your program is the team that runs it on the day. The nurse who handled the cold-chain kit at the wholesaler is the same nurse who logs the AIR record at end of clinic.
That is the closed loop people mean when they talk about a nurse-led model — and the reason the clinical side stays largely a solved problem at our scale.
Image: Corporate Care, 2026.
Clinical credibility your medical director can verify.
Send the brief and your team gets a written response inside one business day.
ATAGI, AIH and AIR — the three letters every workplace flu provider should follow
ATAGI is the Australian Technical Advisory Group on Immunisation. They publish the annual statement that names which population groups should receive influenza vaccination, what the dosing intervals look like, and how to handle co-administration with COVID-19 and other routine vaccines. ATAGI’s 2026 statement is the document our clinical lead reads first every February, and the document every workplace flu provider in Australia should be able to quote from on request.
The Australian Immunisation Handbook chapter 4 is where that statement becomes operational guidance: contraindications, precautions, dosing, special-risk groups, the lot. The Handbook is the reference every Australian immunisation provider works to. The Australian Immunisation Register is where every dose Corporate Care administers gets reported, the same day, under the mandate that has been federal law since 1 March 2021.
ATAGI says it. AIH writes it. AIR records it. A workplace flu provider that can’t hold all three letters at once is missing one of them.
Image: Corporate Care, 2026.
The clinical edge cases we plan for, not around
Most employees in a workplace clinic walk through in two minutes. The work is in the edge cases.
Egg allergy: the Australian Immunisation Handbook position is that people with egg allergy — including a history of anaphylaxis to egg — can be safely vaccinated with any influenza vaccine, unless they have previously had a serious adverse reaction to an influenza vaccine itself.
Your nurse asks about it, vaccinates as normal, and observes them afterwards as we do for everyone. The full detail is in our explainer on flu vaccines and egg allergy.
Pregnancy: influenza vaccine is recommended at any trimester per the AIH; your nurse vaccinates them on the day, the same as everyone else. Immunocompromised: inactivated influenza vaccine remains recommended, and the vaccine we bring is inactivated. Your nurse vaccinates them on the day, the same as everyone else.
Anaphylaxis protocol travels in every clinic kit. Adrenaline auto-injectors, an in-date response plan, post-dose observation chairs set up before the first person sits down. Our nurses are trained to the rare-event response and our internal incident-review process closes the loop within twenty-four hours of anything that triggers it.
The point of a nurse-led model isn’t that edge cases never happen. It’s that when they happen, the same organisation that took the brief is the one that owns the outcome.
Operational proof the clinical model holds at scale
Approximately three thousand workplace sites in the last three years. More than one hundred thousand employees vaccinated across those sites. NPS 92, averaged from 1,000+ employee responses yearly.
No serious adverse-event clusters across the program in the last three years. Every incident is reviewed by the clinical lead within twenty-four hours and reported through the AIR record on the day of the dose.
The numbers aren’t the point on their own, but they answer the only question a medical director needs to ask: does the clinical model hold up when the operational side scales?
It does, and the reason it does is that the clinical model was designed by a Registered Nurse. The same Registered Nurse who ran the first workplace clinic in 2011 still sets how we work today. That continuity is the operational proof. Not the volume, the consistency behind it.
More from our vaccine-science library
- Can the flu shot make you feel sick? — timing, immune response, and what is really going on.
- 8 myths about the flu vaccine — the common ones, sorted.
- Four reasons to get a flu shot every year — why annual matters.
- How the southern-hemisphere flu vaccine is chosen — strain selection each season.
- What is subclade K? — the A(H3N2) strain behind the 2026 vaccine update.
- Common misconceptions about workplace flu shots — three furphies, busted.
- Browse all vaccine science articles.
Talk to us about your 2027 workplace flu program
Tell us your employee count, sites, and any previous-program participants below. We come back with pricing within one business day.
What Our Clients Said
More than 9 in 10 respondents rate us 9 or 10, year after year. NPS 92. Shared with our customers’ permission — quotes are real, lightly edited only for clarity.
“Very positive as the whole experience was simple and straightforward, convenient and efficient.”
“It was really quite good thank you. I believe that the professionalism, humour and perspicacity of the staff onsite was really quite remarkable and reassuring.”
“Seamless and excellent experience! Thanks so much. Would definitely recommend to colleagues.”
“Simple, efficient, friendly, professional… and you came to us :-) What more do you need?”
“Process was so easy, supported with multiple acknowledgements and reminders. Lollipops are always appreciated :-)”
“Satisfied. Service was convenient, easy to use and customer service was friendly.”
“It was a very positive experience — the lady explained everything very well and was very friendly.”
“Easy peasy — thank you for making this an easy routine experience that ticks it off for the year.”
Frequently Asked Questions
A trivalent inactivated influenza vaccine (TIV) covering the three strains the Australian Influenza Vaccine Committee recommended for the Australian 2026 season — two influenza A subtypes (H1N1 and H3N2) and one influenza B lineage (Victoria). The B/Yamagata lineage has not been detected in global circulation since 2020, which is why every flu vaccine on the Australian market in 2026 is trivalent.
Both egg-based and cell-based options are available on the Australian market; Corporate Care administers egg-based inactivated injectable TIV across all standard workplace clinics. Vaccine is purchased through licensed Australian wholesale supply, held under calibrated cold chain between 2°C and 8°C from wholesaler to syringe, and every administration is reported to the Australian Immunisation Register on clinic day.
Run by nurses, in-house, since 2010. Founder Aitor Aspiazu is a Registered Nurse and remains the clinical lead. Every clinic-delivering nurse is on the Corporate Care payroll (not a sub-contracted agency roster), holds current AHPRA registration, and holds HESA-accredited workplace immunisation training.
The team that scopes your brief is the team that runs the clinic, handles the cold chain, and reconciles the AIR record. One organisation, one clinical lead, one closed loop.
The ATAGI annual statement and the Australian Immunisation Handbook influenza chapter are the documents we work to.
The clinical lead reviews both before each season opens, so what your nurse does on the day reflects current guidance. Contraindications, precautions and special-risk-group handling come straight from the Handbook.
Post-dose observation is built into every clinic, and our nurses are trained to manage reactions. Every clinic carries an emergency kit with adrenaline.
In the rare event of anaphylaxis, your nurse gives adrenaline, calls triple zero, and stays with the person until the ambulance arrives.
The event is documented as an adverse event following immunisation (AEFI), recorded internally and reported to the Therapeutic Goods Administration and the relevant state or territory health authority.
Common mild reactions (sore arm, low-grade fever, fatigue) are covered in the information employees receive before the day, so they know what is normal and what warrants a GP visit.
Egg allergy alone is not a contraindication per the Australian Immunisation Handbook. Your nurse asks about it, vaccinates as normal, and observes them afterwards as we do for everyone.
Pregnancy: influenza vaccine is recommended at any stage of pregnancy. Immunocompromised employees: inactivated influenza vaccine remains recommended, and the vaccine we bring is inactivated.
All three are vaccinated on the day, the same as everyone else. If your nurse finds a reason someone should not be vaccinated, they are kindly referred to their GP rather than vaccinated under uncertainty.
Real, and auditable. Vaccine is collected from licensed Australian wholesale supply, transported in a calibrated cold-chain kit with a continuous temperature logger, and held between 2°C and 8°C from collection to the moment the dose enters the syringe. Logger data is available on request.
Any cold-chain breach triggers an immediate batch-quarantine protocol — the dose does not go in the arm. The cold chain is the part of the clinical model that fails silently if you don’t actively run it, which is why we run it the same way every clinic.
One clinical lead, one way of working, one accountable organisation. A pharmacy chain typically delivers workplace flu through a roster of independently-contracted pharmacists, each operating under their own state-specific pharmacy authorisations. A clinic-of-clinics model aggregates sub-contracted GP clinics under a single brand.
Corporate Care’s clinical side is run in-house by Registered Nurses on payroll, under a single clinical lead, with one chain of accountability for cold chain, AIR reporting, and rare-event response. Different model, different liability profile.
Corporate Care acknowledges the Traditional Custodians of the lands across Australia on which we work and live. We pay our respects to Elders past and present, and recognise their continuing connection to land, waters and community.